logo

CORZ

Core Scientific·NASDAQ
--
--(--)
--
--(--)
6.14 / 10
Outperform

Fundamental measurement shows adequate quality (6.1/10). Constructive metrics: Inventory turnover days and PB-ROE, whereas limitations surface in Asset-MV and Days sales outstanding. Final assessment: optimistic.

Fundamental(6.14)SentimentTechnical

Analysis Checks(8/10)

Revenue-MV
Value-1.97
Score3/3
Weight19.34%
1M Return10.44%
Days sales outstanding
Value72.55
Score1/3
Weight0.43%
1M Return0.24%
Profit-MV
Value0.46
Score3/3
Weight13.80%
1M Return7.59%
Net income-Revenue
Value-0.17
Score2/3
Weight5.32%
1M Return3.05%
PB-ROE
Value1.26
Score3/3
Weight22.64%
1M Return13.67%
Rate of return on total assets (%)
Value-26.01
Score3/3
Weight7.54%
1M Return3.53%
Annualized return on total assets (%)
Value-34.68
Score3/3
Weight7.54%
1M Return3.53%
Asset-MV
Value-0.50
Score1/3
Weight10.33%
1M Return5.65%
Inventory turnover days
Value232.28
Score3/3
Weight2.64%
1M Return1.44%
Cash-MV
Value-0.01
Score2/3
Weight10.42%
1M Return6.93%
Is CORZ undervalued or overvalued?
  • CORZ scores 6.14/10 on fundamentals and holds a Discounted valuation at present. Backed by its 0.00% ROE, -229.91% net margin, -6.78 P/E ratio, -4.62 P/B ratio, and 48.94% earnings growth, these metrics solidify its Outperform investment rating.